Viewing Study NCT02819804


Ignite Creation Date: 2025-12-24 @ 8:03 PM
Ignite Modification Date: 2026-03-28 @ 1:56 PM
Study NCT ID: NCT02819804
Status: TERMINATED
Last Update Posted: 2020-02-11
First Post: 2016-06-28
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Nivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Sponsor:
Organization: